Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2025-12-24 @ 2:46 PM
NCT ID:
NCT01271959
Eligibility Criteria:
Inclusion Criteria:
* Pathologically confirmed diagnosis of solid tumor malignancy;
* Medically indicated to receive chemotherapy;
* Fresh tissue submitted from the solid tumor malignancy for testing with the ChemoFx® assay after August, 2006;
* Final ChemoFx® assay report is available;
* Subject must be at least 18 years of age;
* Subject must sign and date an IRB approved ICF.
Exclusion Criteria:
* Enrolled in PT-103, PT-106, PT-206, PT-301, or PT-304;
* Pregnant or lactating subjects;
* Subjects are not indicated to receive chemotherapy for their disease;
* Subjects with psychiatric or addictive disorders that would preclude obtaining informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01271959
Study Brief:
Protocol Section:
NCT01271959